Stemline Targeting cancer at its root
developing novel drugs that attack Cancer Stem Cells

8-K

SEC Filing Details

Document Details

Form
Filing Date
Nov 9, 2017
Document Date
Nov 9, 2017
Form Description
Report of unscheduled material events or corporate event
Filing Group
Current Reports
Company
Stemline Therapeutics
Issuer
STEMLINE THERAPEUTICS INC


Copyright 2018 - Stemline Therapeutics, Inc. All rights reserved